Top Markets
#1 Black Phoenix Black Phoenix +350.33%
#2 Islamic Coin Islamic Coin +158.10%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.42%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.65%
#6 DOVU DOVU +10.14%
#7 Pons Pons +8.51%
#8 stake.link stake.link +8.17%
#9 COTI COTI +7.25%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +6.08%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
EastWest Bioscience Inc. EastWest Bioscience Inc.

EastWest Bioscience Inc.

HBOSF
Rank in Stocks #41907
EastWest Bioscience Inc. is a holistic health enterprise that vertically... EastWest Bioscience Inc. is a holistic health enterprise that vertically integrates its operations, focusing on the production and sale of hemp-based nutritional goods throughout Canada and the United States. Beyond its core offerings, the company manages Sangster's Health Center retail locations, which distribute supplements and other wellness items via a network of franchises and its e-commerce site. Additionally, it participates in the property management sector. Established in 2016, EastWest Bioscience Inc. maintains its primary offices in Penticton, Canada.
Share Price
$0.0001
Last synced: 2023-02-15
Market Cap
$7.78K
Change (1 day)
-99.30%
Change (1 year)
0.00%
Country
CA
Trade EastWest Bioscience Inc. (HBOSF)

Category

Healthcare
P/E ratio for EastWest Bioscience Inc. (HBOSF)
P/E ratio as of 2026 TTM: 0
According to EastWest Bioscience Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for EastWest Bioscience Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 23.71 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 220.17 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.